Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation.

MLA

Ajetunmobi, Olabayo H., et al. “Screening the Medicine for Malaria Venture’s Pandemic Response Box to Identify Novel Inhibitors of Candida Albicans and Candida Auris Biofilm Formation.” APMIS, vol. 131, no. 11, Nov. 2023, pp. 613–25. EBSCOhost, https://doi.org/10.1111/apm.13342.

APA

Ajetunmobi, O. H., Chaturvedi, A. K., Badali, H., Vaccaro, A., Najvar, L., Wormley, F. L., Wiederhold, N. P., Patterson, T. F., & Lopez, R. J. L. (2023). Screening the medicine for malaria venture’s Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation. APMIS, 131(11), 613–625. https://doi.org/10.1111/apm.13342

Chicago

Ajetunmobi, Olabayo H., Ashok K. Chaturvedi, Hamid Badali, Alessandra Vaccaro, Laura Najvar, Floyd L. Wormley, Nathan P. Wiederhold, Thomas F. Patterson, and Ribot, Jose L. Lopez. 2023. “Screening the Medicine for Malaria Venture’s Pandemic Response Box to Identify Novel Inhibitors of Candida Albicans and Candida Auris Biofilm Formation.” APMIS 131 (11): 613–25. doi:10.1111/apm.13342.